| As Firms
Jostle To Lead Beta Blocker Suit Dark Talk
of Copycat Pleadings in SDNY
By Matthew
Russell Lee, Patreon
BBC
- Guardian
UK - Honduras
- ESPN
SDNY COURTHOUSE,
Nov 8 – In a civil antitrust
action against a number of
industry defendants for
unlawful exclusion of generic
substitutes for the branded
drug Bystolic, a beta blocker,
the time as come to pick
interim lead counsel.
On
November 6, 2020 U.S. District
Court for the Southern
District of New York Judge
Lewis J. Liman held a
proceeding. Inner City Press
covered it.
Law firm
after law firm made claims
about its expertise and
commitments to diversity (some
were shown to be thin).
One firm accused
another of filing copycat
lawsuit and said it should get
the assignment and fees.
The case is In re
Bystolic Antitrust Litigation,
20-cv-5735 (Liman)
***
Your
support means a lot. As little as $5 a month
helps keep us going and grants you access to
exclusive bonus material on our Patreon
page. Click
here to become a patron.
Feedback:
Editorial [at] innercitypress.com
SDNY Press Room 480, front cubicle
500 Pearl Street, NY NY 10007 USA
Mail: Box 20047, Dag
Hammarskjold Station NY NY 10017
Reporter's mobile (and weekends):
718-716-3540
Other, earlier Inner City Press are
listed here,
and some are available in the ProQuest
service, and now on Lexis-Nexis.
Copyright 2006-2020 Inner City
Press, Inc. To request reprint or other
permission, e-contact Editorial [at]
innercitypress.com
|
,
